Kendrith M. Rowland

Oncology

602 W University Ave
Urbana, IL 61801

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11.

Engendering Reproductive Health Within Oncologic Survivorship Trial, ECOG-ACRIN E1Q11.

Journal: JCO oncology practice

Published: April 28, 2026

Altered spatial patterns of intrinsic brain activity and cognitive decline in colorectal cancer survivors.

Altered spatial patterns of intrinsic brain activity and cognitive decline in colorectal cancer survivors.

Journal: Journal of cancer survivorship : research and practice

Published: September 22, 2025

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2025

Regional hyperconnectivity in the medial temporal lobes as a maladaptive mechanism for colorectal cancer-related cognitive decline.

Regional hyperconnectivity in the medial temporal lobes as a maladaptive mechanism for colorectal cancer-related cognitive decline.

Journal: Scientific reports

Published: May 21, 2025

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201.

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201.

Journal: The oncologist

Published: May 15, 2025

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 20, 2024

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116).

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 06, 2024

NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms.

NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms.

Journal: The journal of sexual medicine

Published: November 22, 2023

Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.

Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 09, 2021

Colon metastases as first clinical manifestation of lobular breast carcinoma with no subsequent evidence of breast disease.

Colon metastases as first clinical manifestation of lobular breast carcinoma with no subsequent evidence of breast disease.

Journal: BMJ case reports

Published: December 01, 2020

Dose-Response Effects of Acute Aerobic Exercise Duration on Cognitive Function in Patients With Breast Cancer: A Randomized Crossover Trial.

Dose-Response Effects of Acute Aerobic Exercise Duration on Cognitive Function in Patients With Breast Cancer: A Randomized Crossover Trial.

Journal: Frontiers in psychology

Published: March 31, 2020

A pilot feasibility randomized controlled trial adding behavioral counseling to supervised physical activity in prostate cancer survivors: behavior change in prostate cancer survivors trial (BOOST).

A pilot feasibility randomized controlled trial adding behavioral counseling to supervised physical activity in prostate cancer survivors: behavior change in prostate cancer survivors trial (BOOST).

Journal: Journal of behavioral medicine

Published: February 25, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026